vivoPharm Pty Ltd has entered into a partnership with Experimental Pharmacology & Oncology Berlin-Buch GmbH (EPO), one of Germany’s leading preclinical oncology testing company.
vivoPharm Accesses New Cancer Models for US Market
Previous ArticlevivoPharm announces new Chairman of the Board